Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb V) For The Active Ingredient Erythropoietin (Exclusively Epoetin Zeta), (Obo), Atc B03Xa01 For The Period 01.12.2024 - 30.11.2026

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 95634491

  Document Type - Tender Notices

Description - Description: Scope of procurementBrief descriptionSection 130a paragraph 8 of the Social Code Book V enables health insurance companies and pharmaceutical companies to conclude framework discount agreements for the drugs dispensed at the expense of t he statutory health insurance companies. In view of the relevant legal provisions for awarding public contracts, a regular process of active substance-related, formal award procedures takes place through DAK-Gesundheit in accordance with the regulations of Part 4 of the GWB. For drugs containing the above-mentioned active substance, erythropoietin (exclusively epoetin zeta), ATC B03XA01, which are to be specified by the bidder in Annex 2 to the c

Gt Ref Id - 95634491

Deadline - Oct 05, 2026